Analytical Data
-
Gene name
EBF1
- Application
-
Alternative Names
COE1; EBF; O/E-1; OLF1; Transcription Factor COE1
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 95% as determined by SDS-PAGE.
-
Uniprot
Q9UH73
-
Expression Region
Asp179~Ser451
-
Molecular Weight
34/17kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ELF3 (E74-like factor 3) is a member of the Ets transcription factor family, which plays a crucial role in various biological processes, including cell differentiation, proliferation, and oncogenesis. It is characterized by its ability to bind to specific DNA sequences and regulate the expression of target genes, influencing developmental pathways and cellular responses. Recent studies have highlighted the significance of ELF3 in various cancers, showcasing its potential as a biomarker and therapeutic target. The identification of its role in tumor progression and immune response modulation has sparked interest in the development of ELF3-based recombinant proteins for research and therapeutic applications. The production and characterization of ELF3 recombinant proteins enable researchers to explore its functional mechanisms and interactions with other cellular components. Furthermore, understanding ELF3’s involvement in signaling pathways may provide insights into its therapeutic potential in cancer and other diseases. As research evolves, ELF3 is emerging as a promising candidate for targeted therapies, emphasizing the need for extensive studies to elucidate its biological activities and interactions within the cellular environment. Overall, ELF3's functional versatility and significance in pathology make it a focal point for ongoing investigations in molecular biology and therapeutic development.
